These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10159112)

  • 1. Mark Pauly on welfare economics: normative rabbits from positive hats.
    Culyer AJ; Evans RG
    J Health Econ; 1996 Apr; 15(2):243-51; discussion 253-4. PubMed ID: 10159112
    [No Abstract]   [Full Text] [Related]  

  • 2. A model is only as good as its assumptions: a reply to Peele.
    Rice T
    J Health Econ; 1993 Jul; 12(2):209-11. PubMed ID: 10127780
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluating welfare losses in the health care market.
    Peele PB
    J Health Econ; 1993 Jul; 12(2):205-8. PubMed ID: 10127779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demand curves, economists, and desert islands: a response to Feldman and Dowd.
    Rice T
    J Health Econ; 1993 Jul; 12(2):201-4. PubMed ID: 10127778
    [No Abstract]   [Full Text] [Related]  

  • 5. Theory and methods of economic evaluation of health care.
    Johannesson M
    Dev Health Econ Public Policy; 1996; 4():1-245. PubMed ID: 10158916
    [No Abstract]   [Full Text] [Related]  

  • 6. An alternative framework for evaluating welfare losses in the health care market.
    Rice T
    J Health Econ; 1992 May; 11(1):86-92. PubMed ID: 10119758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The end of asymmetric information.
    Robinson JC
    J Health Polit Policy Law; 2001 Oct; 26(5):1045-53. PubMed ID: 11765255
    [No Abstract]   [Full Text] [Related]  

  • 8. What does the demand curve for medical care measure?
    Feldman R; Dowd B
    J Health Econ; 1993 Jul; 12(2):193-200. PubMed ID: 10127777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A re-examination of the meaning and importance of supplier-induced demand.
    Pauly MV
    J Health Econ; 1994 Oct; 13(3):369-72. PubMed ID: 10138861
    [No Abstract]   [Full Text] [Related]  

  • 10. Can efficiency in health care be left to the market?
    Reinhardt UE
    J Health Polit Policy Law; 2001 Oct; 26(5):967-92. PubMed ID: 11765275
    [No Abstract]   [Full Text] [Related]  

  • 11. Uncertainty and the welfare economics of medical care. 1963.
    Arrow KJ
    Bull World Health Organ; 2004 Feb; 82(2):141-9. PubMed ID: 15042238
    [No Abstract]   [Full Text] [Related]  

  • 12. Severity of illness and the welfare effects of moral hazard.
    Eisenhauer JG
    Int J Health Care Finance Econ; 2006 Dec; 6(4):290-9. PubMed ID: 17136599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drawing a veil over the measurement of social welfare--a reply to Johannesson.
    Dolan P
    J Health Econ; 1999 Jun; 18(3):387-90. PubMed ID: 10537902
    [No Abstract]   [Full Text] [Related]  

  • 14. The welfare impact of HMO mergers.
    Town R
    J Health Econ; 2001 Nov; 20(6):967-90. PubMed ID: 11758055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On aggregating QALYs: a comment on Dolan.
    Johannesson M
    J Health Econ; 1999 Jun; 18(3):381-6. PubMed ID: 10537901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The welfare economics of moral hazard.
    Nyman JA; Maude-Griffin R
    Int J Health Care Finance Econ; 2001 Mar; 1(1):23-42. PubMed ID: 14626005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Welfare gains from user charges for government health services.
    Griffin DC
    Health Policy Plan; 1992 Jun; 7(2):177-80. PubMed ID: 10119708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The costs and effects of addressing the needs of vulnerable populations: results of 10 years of research.
    Browne G; Roberts J; Byrne C; Gafni A; Weir R; Majumdar B
    Can J Nurs Res; 2001 Jun; 33(1):65-76. PubMed ID: 11928156
    [No Abstract]   [Full Text] [Related]  

  • 19. Pricing and welfare implications of parallel imports in the pharmaceutical industry.
    Jelovac I; Bordoy C
    Int J Health Care Finance Econ; 2005 Mar; 5(1):5-21. PubMed ID: 15714261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A re-examination of the meaning and importance of supplier-induced demand.
    Labelle R; Stoddart G; Rice T
    J Health Econ; 1994 Oct; 13(3):347-68. PubMed ID: 10138860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.